• Home
  • NEW DAY MEDICINE
  • 2 (88) 2026
  • 166 -2 (88) 2026 - F.R. Karimova - INTEGRATIVE THERAPY IN CHRONIC ALLERGIC DERMATITIS: ANALYSIS OF CLINICAL OUTCOMES AND LONG-TERM REMISSION

166 -2 (88) 2026 - F.R. Karimova - INTEGRATIVE THERAPY IN CHRONIC ALLERGIC DERMATITIS: ANALYSIS OF CLINICAL OUTCOMES AND LONG-TERM REMISSION

INTEGRATIVE THERAPY IN CHRONIC ALLERGIC DERMATITIS: ANALYSIS OF CLINICAL OUTCOMES AND LONG-TERM REMISSION

F.R. Karimova - Bukhara State Medical Institute named after Abu Ali ibn Sinа

Resume

This study was aimed at the comparative evaluation of the clinical effectiveness of standard medical protocols and traditional medicine approaches in the treatment of chronic allergic dermatitis. A total of 298 patients were included, comprising 138 males and 160 females. Clinical parameters (itch intensity, erythema area, skin dryness), remission duration, and relapse frequency were analyzed. Standard therapy resulted in a significant reduction of symptoms (p<0.01; p<0.001); however, the mean remission duration was 3.7–3.9 months, and one in four patients required additional therapy. Traditional remedies (aloe extract and goose fat-based topical formulations) contributed to symptom relief and restoration of the skin barrier, although the rate of clinical improvement was slower. The integrative approach demonstrated prolonged remission and reduced relapse rates. These findings support the implementation of a comprehensive and individualized therapeutic strategy for chronic allergic dermatitis.

Keywords: chronic allergic dermatitis, standard therapy, traditional medicine, aloe, goose fat, remission, relapse, skin barrier function.

First page

894

Last page

899

For citation:F.R. Karimova - INTEGRATIVE THERAPY IN CHRONIC ALLERGIC DERMATITIS: ANALYSIS OF CLINICAL OUTCOMES AND LONG-TERM REMISSION//New Day in Medicine 2(88)2026 894-899 https://newdayworldmedicine.com/en/new_day_medicine/2-88-2026

List of References

  1. Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022;21(1):21–40.
  2. Cork MJ, Danby SG, Ogg GS. Atopic dermatitis epidemiology and unmet need in the United Kingdom. J Dermatolog Treat. 2020;31(8):801–809.
  3. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2023;88(2):407–450.
  4. Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Immunol Res. 2020;12(1):84–99.
  5. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345–360.
  6. Lee SY, Jeong SH, Kim DW. Effects of aloe vera gel in patients with chronic inflammatory skin diseases: A systematic review. Complement Ther Med. 2021;57:102636.
  7. Purnamawati S, Indrastuti N, Danarti R, Saefudin T. The role of moisturizers in addressing various kinds of dermatitis: A review. Clin Med Res. 2020;18(2):75–87.
  8. Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2021;39(3):259–268.
  9. Weidinger S, Novak N. Atopic dermatitis. Lancet. 2019;387(10023):1109–1122.
  10. Wollenberg A, Christen-Zäch S, Taieb A, et al. ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020;34(12):2717–2744.

    file

    download